Health-related social needs increased for Medicare and Medicaid beneficiaries during the pandemic

Generalised myasthenia gravis is a rare condition – but UCB’s Rystiggo enters a competitive market. Source: Shutterstock / Giovanni Cancemi. Belgian biopharmaceutical company UCB has

ITM Iso­tope Tech­nolo­gies Mu­nich plans to seek ap­proval for its β-emit­ting ra­di­oli­gand in gas­troen­teropan­cre­at­ic neu­roen­docrine tu­mors (GEP-NETs) fol­low­ing a Phase 3 suc­cess, the biotech said